Table 1.
Medication | Indication | Comment | References | ||
---|---|---|---|---|---|
COPD | steroids | inhaled | long-term therapy # | good safety profile | [57] |
systemic | exacerbation | pro-arrhythmic potential | [58] | ||
beta agonists | short acting | exacerbation long-term therapy | pro-arrhythmic potential (high doses) | [50,51,52,59] | |
long acting | long-term therapy | acceptable safety profile | |||
muscarinic antagonists | short acting | exacerbation long-term therapy | pro-arrhythmic potential (high doses) | [50,52,60] | |
long acting | long-term therapy | acceptable safety profile | |||
PDE inhibitors | Roflumilast | long-term therapy | reduction of cardiovascular events | [12] | |
Theophylline | (long-term therapy) | narrow therapeutic range and considerable pro-arrhythmic potential | [57,61] | ||
Cardiovascular Disease | beta blockers | selective | heart failure, CHD, ACS, AHT, SVT, VT | often withheld or under dosed, prefer selective substances, overall good safety profile | [40,41] |
non-selective | |||||
antiplatelet therapy | CHD, ACS | dyspnea caused by reversible P2Y₁₂-antagonists (Ticagrelor, Cangrelor) | [47] | ||
Ivabradine | CHD, heart failure | alternative to beta blockers for anti-anginal and frequency control (sinus rhythm only) | [42,62] | ||
statins | CHD, dyslipidemia | secondary prevention, pleiotropic effects of immune system and inflammation | [14,15] | ||
ACE inhibitors | AHT, heart failure | no bronchoconstriction | [45,46] | ||
angiotensin receptor blockers | alternative (ACE inhibitor induced cough) | ||||
calcium channel blockers | AHT, CHD, SVT | alternative to beta blockers for anti-anginal and frequency control, smooth muscle relaxation (small clinical effect) | [42] | ||
nitrates | CHD | alternative to beta blockers for anti-anginal control | [42] | ||
amiodarone | SVT, VT | pulmonary toxicity | [63] |
COPD: chronic obstructive pulmonary disease, PDE: phosphodiesterase, ACS: acute coronary syndrome, AHT: arterial hypertension, SVT: supraventricular tachyarrhythmia, VT: ventricular supraventricular, CHD: coronary heart disease, ACE: angiotensin converting enzyme. # in selected patients with frequent exacerbations or blood eosinophilia (see text for details).